Home
Browse All Titles
Sign In
Browse All Titles
Nurse's Chemotherapy Quick Pocket Reference
Treatment Cycle A (cycles 1,3, 5, and 7)
Table of Contents
Free Topics
5-Fluorouracil (Continuous Infusion)
About
Cyclophosphamide + Doxorubicin + 5-Flourouracil (CAF)
Cyclophosphamide + Doxorubicin + 5-Flourouracil (CAF)
Cyclophosphamide + Doxorubicin + 5-Flourouracil (CAF-Oral)
Cyclophosphamide + Epirubicin + 5-Fluorouracil (CEF)
Cyclophosphamide + Methotrexate + 5-Flourouracil (CMF IV Bolus)
Cyclophosphamide + Methotrexate + 5-Flourouracil (CMF-Bonadonna Regimen)
Cyclophosphamide + Methotrexate + 5-Flourouracil (CMF-Bonadonna Regimen)
Cyclophosphamide + Methotrexate + 5-Flourouracil (CMF-IV Regimen)
Preface
Streptozocin + Mitomycin + 5-Fluorouracil (SMF)
Anal Cancer
5-FU + Cisplatin + Radiation Therapy (MD Anderson Regimen)
5-FU + Mitomycin + Radiation Therapy (EORTC Regimen)
5-FU + Mitomycin + Radiation Therapy (Wayne State Regimen)
Metastatic Disease and/Or Salvage Chemotherapy
5-FU and Cisplatin
Biliary Cancer
Gemcitabine + Capecitabine
Gemcitabine + Cisplatin
Bladder Cancer
Combination Regimens
Cisplatin + Methotrexate + Vinblastine (CMV)
Cisplatin + Methotrexate + Vinblastine + XRT (CMV + Radiation Therapy)
Cyclophosphamide + Doxorubicin + Cisplatin (CAP)
Cyclophosphamide + Doxorubicin + Cisplatin (CISCA)
Gemcitabine + Cisplatin
Ifosfamide + Paclitaxel + Cisplatin (ITP)
Methotrexate + Vinblastine + Doxorubicin + Cisplatin (MVAC)
Paclitaxel + Carboplatin
Single-Agent Regimens
Gemcitabine
Paclitaxel
Bone Metastasis
Pamidronate
Zometa
Brain Cancer
Adjuvant Therapy
BCNU (Carmustine) - Single-Agent Regimens
Procarbazine + Lomustine + Vincristine (PCV) - Combination Regimens
Temozolomide + Radiation Therapy - Combination Regimens
Advanced Disease
BCNU (Carmustine) - Single-Agent Regimens
Irinotecan - Single-Agent Regimens
Procarbazine - Single-Agent Regimens
Procarbazine + Lomustine + Vincristine (PCV) - Combination Regimens
Temozolomide - Single-Agent Regimens
Breast Cancer
Adjuvant Therapy
5-Fluorouracil + Epirubicin + Cyclophosphamide (FEC) - Combination Regimens
Anastrozole (Arimidex) - Single-Agent Regimens
Cyclophosphamide + Doxorubicin + 5-Flourouracil (CAF) - Combination Regimens
Cyclophosphamide + Doxorubicin + 5-Flourouracil (CAF-Oral) - Combination Regimens
Cyclophosphamide + Methotrexate + 5-Flourouracil (CMF-Bonadonna Regimen) - Combination Regimens
Cyclophosphamide + Methotrexate + 5-Flourouracil (CMF-IV Regimen) - Combination Regimens
Cyclophosphamide + Methotrexate + 5-FU + Prednisone (CMFP) - Combination Regimens
Docetaxel + Cyclophosphamide (TC) - Combination Regimens
Docetaxel + Doxorubicin + Cyclophosphamide (TAC) - Combination Regimens
Doxorubicin + CMF - Combination Regimens
Doxorubicin + Cyclophosphamide (AC) - Combination Regimens
Doxorubicin + Cyclophosphamide followed by Paclitaxel (AC followed by T) - Combination Regimens
Doxorubicin + Cyclophosphamide followed by Paclitaxel + Trastuzumab (AC followed by T + Trastuzumab) - Combination Regimens
Doxorubicin + Paclitaxel + Cyclophosphamide (A + T + C Dose-Dense Therapy) - Combination Regimens
Tamoxifen (Nolvadex) - Single-Agent Regimens
Tamoxifen + Exemestane - Single-Agent Regimens
Tamoxifen + Letrozole - Single-Agent Regimens
Neoadjuvant Therapy
Doxorubicin + Cyclophosphamide + Docetaxel (ACT) - Combination Regimens
Metastatic Breast Cancer
Combination Regimens
5-Fluorouracil + Epirubicin + Cyclophosphamide (FEC-100)
Capecitabine + Docetaxel (XT)
Capecitabine + Paclitaxel (XP)
Capecitabine + Vinorelbine (XN)
Carboplatin + Docetaxel
Carboplatin + Paclitaxel
Cyclophosphamide + Doxorubicin + 5-Flourouracil (CAF)
Cyclophosphamide + Epirubicin + 5-Fluorouracil (CEF)
Cyclophosphamide + Methotrexate + 5-Flourouracil (CMF IV Bolus)
Cyclophosphamide + Methotrexate + 5-Flourouracil (CMF-Bonadonna Regimen)
Docetaxel + Doxorubicin
Doxorubicin + Cyclophosphamide (AC)
Doxorubicin + Paclitaxel (AT)
Gemcitabine + Paclitaxel
Ixabepilone (Ixempra) + Capecitabine
Lapatinib (Tykerb) + Capecitabine (Xeloda)
Mitomycin + Vinblastine
Paclitaxel + Vinorelbine
Trastuzumab + Docetaxel
Trastuzumab + Paclitaxel
Vinorelbine + Doxorubicin
Single-Agent Regimens
Anastrozole (Arimidex)
Capecitabine (Xeloda)
Docetaxel
Doxorubicin
Exemestane (Aromasin)
Fulvestrant (Faslodex)
Gemcitabine
Ixabepilone (Ixempra)
Letrozole (Femara)
Liposomal Doxorubicin (Doxil)
Megestrol (Megace)
Paclitaxel
Paclitaxel Protein-Bound Particles for Injectable Suspension (Abraxane)
Tamoxifen
Toremifene Citrate (Fareston)
Trastuzumab (Herceptin Every 3 Weeks)
Trastuzumab (Herceptin Weekly Dosing)
Vinorelbine
Cancer Of Unknown Primary
Cisplatin + Etoposide + Bleomycin (PEB)
Etoposide + Cisplatin (EP)
Gemcitabine + Carboplatin + Paclitaxel (GCP)
Paclitaxel + Carboplatin + Etoposide (PCE)
Carcinoid Tumors
Combination Regimens
5-Fluorouracil + Streptozocin
Cisplatin + Etoposide
Doxorubicin + Streptozocin
Single-Agent Regimens
Octreotide or Sandostatin LAR Depot (Octreotide Acetate Injectable Suspension)
Cervical Cancer
Combination Regimens
Bleomycin + Ifosfamide + Mesna + Carboplatin (BIC)
Bleomycin + Ifosfamide + Mesna + Cisplatin (BIP)
Cisplatin + 5-Fluorouracil
Cisplatin + Irinotecan
Cisplatin + Radiation Therapy
Cisplatin + Topotecan
Cisplatin + Vinorelbine
Mitomycin + Vincristine + Bleomycin + Cisplatin (MOBP)
Paclitaxel + Cisplatin
Single-Agent Regimens
Cisplatin
Docetaxel
Irinotecan (weekly)
Paclitaxel
Topotecan
Vinorelbine
Colorectal Cancer
Adjuvant Therapy
5-Fluorouracil + Leucovorin (Mayo Clinic Regimen)
5-Fluorouracil + Leucovorin (Weekly Schedule/ High Dose)
5-Fluorouracil + Leucovorin (Weekly Schedule/Low Dose)
Capecitabine (Xeloda)
Oxaliplatin + 5-Fluorouracil + Leucovorin (FOLFOX 4)
Metastatic Disease
5-Fluorouracil (Continuous Infusion) - Single-Agent Regimens
5-Fluorouracil + Leucovorin (de Gramont Regimen) - Combination Regimens
5-Fluorouracil + Leucovorin (German Schedule/Low Dose) - Combination Regimens
5-Fluorouracil + Leucovorin (Mayo Clinic Regimen) - Combination Regimens
5-Fluorouracil + Leucovorin (Roswell Park Regimen/ High Dose) - Combination Regimens
5-Fluorouracil + Leucovorin + Bevacizumab - Combination Regimens
Bevacizumab + IV 5-fluorouracil-based chemotherapy - Combination Regimens
Capecitabine (Xeloda) - Single-Agent Regimens
Capecitabine + Irinotecan (XELIRI) - Combination Regimens
Capecitabine + Oxaliplatin (XELOX) + Bevacizumab - Combination Regimens
Capecitabine + Oxaliplatin (XELOX) or (Capox) - Combination Regimens
Cetuximab (Erbitux) - Single-Agent Regimens
Cetuximab + Irinotecan - Combination Regimens
Floxuridine - Hepatic Artery Infusion
FOLFOX4 + Bevacizumab - Combination Regimens
Irinotecan (CPT-11/Monthly Schedule) - Single-Agent Regimens
Irinotecan (CPT-11/Weekly Schedule) - Single-Agent Regimens
Irinotecan + 5-Fluorouracil + Leucovorin (FOLFIRI Regimen) - Combination Regimens
Irinotecan + 5-Fluorouracil + Leucovorin (IFL-Saltz Regimen) - Combination Regimens
Irinotecan + 5-Fluorouracil + Leucovorin (IFL-Saltz Regimen) + Bevacizumab (BV) - Combination Regimens
Irinotecan + 5-Fluorouracil + Leucovorin (Modified IFL-Saltz Regimen) - Combination Regimens
Irinotecan + 5-Fluorouracil + Leucovorin-(Douillard Regimen) - Combination Regimens
Oxaliplatin + 5-Fluorouracil + Leucovorin (FOLFOX4) - Combination Regimens
Oxaliplatin + 5-Fluorouracil + Leucovorin (FOLFOX6) - Combination Regimens
Oxaliplatin + 5-Fluorouracil + Leucovorin (FOLFOX7) - Combination Regimens
Oxaliplatin + Irinotecan (IROX Regimen) - Combination Regimens
Panitumumab (Vectibix) - Single-Agent Regimens
Trimetrexate + 5-Fluorouracil + Leucovorin - Combination Regimens
Neoadjuvant Combined Modality Therapy
5-Fluorouracil + Radiation Therapy (German AIO Regimen) - Combination Regimens
Capecitabine + Radiation Therapy - Combination Regimens
Endometrial Cancer
Combination Regimens
Cisplatin + Doxorubicin + Paclitaxel
Cyclophosphamide + Doxorubicin + Cisplatin (CAP)
Doxorubicin + Cisplatin (AP)
Doxorubicin + Cyclophosphamide (AC)
Doxorubicin + Paclitaxel (AT)
Paclitaxel and Carboplatin
Single-Agent Regimens
Doxorubicin
Medroxyprogesterone
Megestrol
Paclitaxel
Topotecan
Esophageal Cancer
Combination Regimens
5-FU + Cisplatin + Paclitaxel + Radiation Therapy (Hopkins/Yale Regimen)
5-FU + Cisplatin + Radiation Therapy (Herskovic Regimen)
Metastatic Disease
5-FU + Cisplatin
5-FU + Cisplatin + Definitive Radiation Therapy
Irinotecan + Cisplatin
Paclitaxel - Single-Agent Regimens
Paclitaxel + Cisplatin
Gastric Cancer
Adjuvant Therapy
5-Fluorouracil - Single-Agent Regimens
5-Fluorouracil + Doxorubicin + Methotrexate (FAMTX) - Combination Regimens
5-Fluorouracil + Doxorubicin + Mitomycin (FAM) - Combination Regimens
5-FU + Cisplatin (CF) - Combination Regimens
Chemoradiation Therapy
Docetaxel - Single-Agent Regimens
Docetaxel + Cisplatin - Combination Regimens
Docetaxel + Cisplatin + 5-FU (DCF) - Combination Regimens
Docetaxel + Cisplatin + 5-FU (TCF) - Combination Regimens
Epirubicin + Cisplatin + Fluorouracil (ECF) - Combination Regimens
Etoposide + Doxorubicin + Cisplatin (EAP) - Combination Regimens
Etoposide + Leucovorin + Fluorouracil (ELF) - Combination Regimens
Fluorouracil + Doxorubicin + Cisplatin (FAP) - Combination Regimens
Irinotecan + Cisplatin (IP) - Combination Regimens
Gastrointestinal Stromal Tumor (GIST)
Single-Agent Regimens
Imatinib (Gleevec)
Sunitinib (Sutent)
Head and Neck Cancer
Combination Regimens
5-FU + Cisplatin (PF)
Carboplatin + Fluorouracil
Chemoradiotherapy for Nasopharyngeal Cancer
Cisplatin + Fluorouracil + Leucovorin (PFL)
Cisplatin + Fluorouracil + Radiation Therapy (PF-Larynx Preservation)
Concurrent Chemoradiation Therapy for Laryngeal Preservation
Docetaxel + Cisplatin + 5-FU (TPF)
Paclitaxel + Carboplatin
Paclitaxel + Cisplatin
Paclitaxel + Ifosfamide + Mesna + Carboplatin (TIC)
Paclitaxel + Ifosfamide + Mesna + Cisplatin (TIP)
Vinorelbine + Cisplatin (VP)
Single-Agent Regimens
Capecitabine (Xeloda)
Docetaxel
Methotrexate
Paclitaxel
Vinorelbine
Hepatocellular Cancer
Single-Agent Regimens
Capecitabine (Xeloda)
Cisplatin
Doxorubicin
Kaposi’s Sarcoma
Combination Regimens
Bleomycin + Vincristine (BV)
Doxorubicin + Bleomycin + Vinblastine (ABV)
Single-Agent Regimens
Interferon alpha-2a
Liposomal Daunorubicin (DaunoXome)
Liposomal Doxorubicin (Doxil)
Paclitaxel (Taxol)
Leukemia: Acute Lymphocytic Leukemia (ALL)
Hyper-Cvad Regimen
Clofarabine - Single-Agent Regimens
CNS Prophylaxis
High-Dose Methotrexate/Cytarabine
Hyper-Cvad Regimen
Induction Therapy
Supportive Care
Larson Regimen
CNS Prophylaxis and Interim Maintenance (Weeks 13-25)
Early Intensification (Weeks 5-12)
Induction Therapy (Weeks 1-4)
Larson Regimen
Late Intensification (Weeks 26-33)
Prolonged Maintenance
Linker Regimen
CNS Prophylaxis
Consolidation Therapy
Induction Therapy
Maintenance Therapy
Treatment B (cycles 2, 4, 6, and 8) - Consolidation Therapy
Treatment C (cycle 9) - Consolidation Therapy
Treatment Cycle A (cycles 1,3, 5, and 7) - Consolidation Therapy
Leukemia: Acute Lymphocytic Leukemia: Relapsed Or Refractory Ph + ALL
Single-Agent Regimens
Imatinib (Gleevec)
Leukemia: Acute Myelogenous Leukemia (AML)
Consolidation Regimens
Ara-C + Daunorubicin (5 + 2)
Ara-C + Idarubicin
Induction Regimens
Ara-C + Doxorubicin
Ara-C + Idarubicin
Ara-C 1 Daunorubicin (7 1 3)
Relapse AML
FLAG: Fludarabine + Cytarabine + G-CSF
Mitoxantrone + Etoposide (MV)
Single-Agent Regimens
Cladribine (Leustatin)
Gemtuzumab (Mylotarg)
High-Dose Cytarabine (HiDAC)
Leukemia: Acute Promyelocytic Leukemia (APL)
Combination Regimens
All-Trans-Retinoic Acid + Idarubicin (AIDA)
Single-Agent Regimens
All-Trans-Retinoic Acid (Vesanoid, Tretinoin, ATRA)
Arsenic Trioxide (Trisenox)
Leukemia: Chronic Lymphocytic Leukemia (CLL)
Combination Regimens
Chlorambucil + Prednisone (CP)
Cyclophosphamide + Fludarabine (CF)
Cyclophosphamide + Vincristine + Prednisone (CVP)
Fludarabine + Cyclophosphamide + Rituxan (FCR)
Fludarabine + Prednisone (FP)
Fludarabine + Rituxan (FR)
Single-Agent Regimens
Alemtuzumab (Campath)
Bendamustine (Treanda)
Chlorambucil
Cladribine (Leustatin, 2-CdA)
Fludarabine
Prednisone
Leukemia: Chronic Myelogenous Leukemia (CML)
Combination Regimens
Interferon + Cytarabine (Ara-C)
Single-Agent Regimens
Busulfan (Myleran)
Dasatinib (Sprycel)
Hydroxyurea
Imatinib (Gleevec)
Interferon alpha-2b
Nilotinib (Tasigna)
Leukemia: Cutaneous T-Cell Leukemia (CTCL)
Denileukin Diftitox (ONTAK)
Leukemia: Hairy Cell Leukemia
Cladribine (Leustatin, 2-CdA)
Interferon alpha-2a
Pentostatin
Lung Cancer: Non-Small Cell Lung Cancer
Adjuvant Therapy
Paclitaxel + Carboplatin - Combination Regimens
Vinorelbine + Cisplatin - Combination Regimens
Metastatic Disease
Bevacizumab (Avastin) + Carboplatin + Paclitaxel - Combination Regimens
Carboplatin + Paclitaxel - Combination Regimens
Cisplatin + Paclitaxel - Combination Regimens
Docetaxel - Single-Agent Regimens
Docetaxel + Carboplatin - Combination Regimens
Docetaxel + Cisplatin - Combination Regimens
Docetaxel + Gemcitabine - Combination Regimens
Erlotinib (Tarceva) - Single-Agent Regimens
Etoposide + Cisplatin (EP) - Combination Regimens
Etoposide + Cisplatin + Docetaxel - Combination Regimens
Gefitinib (Iressa) - Single-Agent Regimens
Gemcitabine - Single-Agent Regimens
Gemcitabine + Carboplatin - Combination Regimens
Gemcitabine + Cisplatin - Combination Regimens
Gemcitabine + Vinorelbine - Combination Regimens
Paclitaxel - Single-Agent Regimens
Pemetrexed (Alimta) - Single-Agent Regimens
Topotecan - Single-Agent Regimens
Vinorelbine - Single-Agent Regimens
Vinorelbine + Carboplatin - Combination Regimens
Vinorelbine + Cisplatin - Combination Regimens
Lung Cancer: Small Cell Lung Cancer
Combination Regimens
Carboplatin + Paclitaxel + Etoposide
Cyclophosphamide + Doxorubicin + Etoposide (CAE)
Cyclophosphamide + Doxorubicin + Vincristine (CAV)
Etoposide + Carboplatin
Etoposide + Cisplatin
Irinotecan + Cisplatin
Single-Agent Regimens
Etoposide
Paclitaxel
Topotecan
Lymphoma: Hodgkin’s Disease
Combination Regimens
Bleomycin + Etoposide + Doxorubicin + Cyclophosphamide + Vincristine + Procarbazine + Prednisone (BEACOPP Escalated)
Bleomycin + Etoposide + Doxorubicin + Cyclophosphamide + Vincristine + Procarbazine + Prednisone (BEACOPP)
Carmustine + Etoposide + Cytarabine + Melphalan (Mini-BEAM)
Doxorubicin + Bleomycin + Vinblastine + Dacarbazine (ABVD)
Etoposide + Vinblastine + Cytarabine + Cisplatin (EVAP)
Etoposide + Vincristine + Doxorubicin (EVA)
MOPP Alternating with ABVD
MOPP/ABVD Hybrid
Nitrogen Mustard + Vincristine + Procarbazine + Prednisone (MOPP)
Stanford V
Single-Agent Regimens
Gemcitabine (Gemzar)
Lymphoma: Non-Hodgkin’s Lymphoma
Cd20+ B-Cell Lymphomas
CHOP + Rituximab (GELA study)
CHOP + Rituximab (vose or Nebraska regimen)
High-Grade
CNS Prophylaxis
Magrath Protocol (Burkitt's lymphoma)
Regimen A-CODOX-M (alternate with regimen B-IVAC)
Regimen B-IVAC - CNS Prophylaxis
Stanford Regimen (small non-cleaved cell and Burkittâs lymphoma) - CNS Prophylaxis
Intermediate-Grade
Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP)
Cyclophosphamide + Mitoxantrone + Oncovin + Prednisone (CNOP)
Etoposide + Prednisone + Oncovin + Cyclophosphamide + Doxorubicin + Rituximab (EPOCH + Rituximab)
Etoposide + Prednisone + Vincristine + Cyclophosphamide + Doxorubicin (EPOCH)
Methotrexate + Bleomycin + Doxorubicin + Cyclophosphamide + Vincristine + Dexamethasone (m-BACOD)
Methotrexate + Doxorubicin + Cyclophosphamide + Oncovin + Prednisone + Bleomycin (MACOP-B)
ProMACE/CytaBOM
Low-Grade
Cyclophosphamide + Doxorubicin + Vincristine + Prednisone (CHOP) - Combination Regimens
Cyclophosphamide + Mitoxantrone (Novantrone) + Vincristine (Oncovin) + Prednisone (CNOP) - Combination Regimens
Cyclophosphamide + Vincristine + Prednisone (CVP) - Combination Regimens
Cyclophosphamide + Vincristine + Prednisone (CVP) + Rituxan - Combination Regimens
Cyclophosphamide + Vincristine + Prednisone (CVP) followed by Rituxan - Combination Regimens
Fludarabine + Cyclophosphamide (FC) - Combination Regimens
Fludarabine + Mitoxantrone (Novantrone) + Dexamethasone (FND) - Combination Regimens
Mantle Cell Lymphoma
Bortezomib (Velcade)
Primary CNS Lymphoma
Cladribine (Leustatin) - Single-Agent Regimens
Fludarabine - Single-Agent Regimens
I 131-Tositumomab (Bexxar) - Single-Agent Regimens
Ibritumomab Tiuxetan (Zevalin) Regimen - Single-Agent Regimens
Methotrexate + IT Methotrexate + Leucovorin + Vincristine + Procarbazine followed by Whole Brain Irradiation
Rituxan (Rituximab) - Single-Agent Regimens
Salvage Regimens
Dexamethasone + High-Dose Cytarabine + Cisplatin (DHAP)
Etoposide + Cytarabine + Cisplatin (ESHAP)
Ifosfamide + Etoposide + Carboplatin (ICE)
Mesna + Ifosfamide + Mitoxantrone + Etoposide (MINE)
Lymphoma: Cutaneous T-Cell Lymphoma (CTCL)
Single-Agent Regimens
Vorinostat (Zolinza)
Malignant Melanoma
Adjuvant Therapy
Interferon alpha-2b
Metastatic Disease
Aldesleukin (IL-2) - Single-Agent Regimens
Cisplatin + Vinblastine + Dacarbazine (CVD) - Combination Regimens
Cisplatin + Vinblastine + Dacarbazine + IL-2 + Interferon - Combination Regimens
Dacarbazine (DTIC) - Single-Agent Regimens
Dacarbazine (DTIC) + Carmustine (BCNU) + Cisplatin - Combination Regimens
DTIC + Cisplatin + BCNU + Tamoxifen - Combination Regimens
Interferon - Single-Agent Regimens
Interferon (IFN) + DTIC - Combination Regimens
Temozolomide - Single-Agent Regimens
Temozolomide + Thalidomide - Combination Regimens
Malignant Mesothelioma
Combination Regimens
Cyclophosphamide + Doxorubicin + Cisplatin (CAP)
Doxorubicin + Cisplatin
Gemcitabine + Carboplatin
Gemcitabine + Cisplatin
Pemetrexed + Cisplatin
Multiple Myeloma
Combination Regimens
Lenalidomide (Revlimid) + Dexamethasone
Liposomal Doxorubicin (Doxil) + Bortezomib (Velcade)
M2 Protocol
Melphalan + Prednisone
Thalidomide + Dexamethasone
Vincristine + Carmustine + Melphalan + Cyclophosphamide + Prednisone (VBMCP)
Vincristine + Doxorubicin + Dexamethasone (VAD)
Single-Agent Regimens
Bortezomib (Velcade)
Dexamethasone
Interferon alpha-2b
Melphalan
Thalidomide
Myelodysplastic Syndrome
Single-Agent Regimens
Arsenic Trioxide (Trisenox)
Azacitidine (Vidaza)
Decitabine (Dacogen)
Lenalidomide (Revlimid)
Ovarian Cancer
Combination Regimens
Carboplatin + Cyclophosphamide (CC)
Carboplatin + Docetaxel
Carboplatin + Paclitaxel
Cisplatin + Cyclophosphamide (CP)
Cisplatin + Paclitaxel (CT)
Gemcitabine + Carboplatin
Gemcitabine + Cisplatin
Gemcitabine + Liposomal Doxorubicin
Intraperitoneal (IP) Cisplatin + Paclitaxel
Single-Agent Regimens
Altretamine (Hexalen)
Etoposide
Gemcitabine
Liposomal Doxorubicin (Doxil)
Paclitaxel
Topotecan
Ovarian Cancer: Germ Cell
Combination Regimens
Etoposide + Bleomycin + Cisplatin (BEP)
Pancreatic Cancer
Locally Advanced Disease
5-Fluorouracil + Radiation Therapy (GITSG)
Metastatic Disease
5-Fluorouracil + Doxorubicin + Mitomycin (FAM) - Combination Regimens
5-Fluorouracil + Leucovorin - Combination Regimens
Capecitabine (Xeloda) - Single-Agent Regimens
Gemcitabine - Single-Agent Regimens
Gemcitabine + Capecitabine (Xeloda) - Combination Regimens
Gemcitabine + Cisplatin - Combination Regimens
Gemcitabine + Cisplatin (fixed dose rate) - Combination Regimens
Gemcitabine + Cisplatin (modified) - Combination Regimens
Gemcitabine + Docetaxel + Capecitabine (GTX) - Combination Regimens
Gemcitabine + Erlotinib (Tarceva) - Combination Regimens
Gemcitabine + Irinotecan (Gemiri) - Combination Regimens
Gemcitabine + Oxaliplatin (GemOx) - Combination Regimens
Streptozocin + Mitomycin + 5-Fluorouracil (SMF) - Combination Regimens
Prostate Cancer
Combination Regimens
Docetaxel + Estramustine
Docetaxel + Prednisone
Estramustine + Etoposide
Estramustine + Vinblastine
Flutamide + Goserelin
Flutamide + Leuprolide
Mitoxantrone + Prednisone
Paclitaxel + Estramustine
Single-Agent Regimens
Aminoglutethimide (Cytadren)
Bicalutamide
Docetaxel
Estramustine
Flutamide
Goserelin (Zoladex)
Ketoconazole
Leuprolide (Lupron)
Nilutamide
Paclitaxel
Prednisone
Renal Cell Cancer
Combination Regimens
5-Fluorouracil + Gemcitabine
Interferon alpha-2a + IL-2
Single-Agent Regimens
Interferon alpha-2a
Low-Dose IL-2 (Aldesleukin)
Sorafenib (Nexavar)
Sunitinib Malate (Sutent)
Temsirolimus (Torisel)
Soft Tissue Sarcomas
Combination Regimens
Cyclophosphamide + Doxorubicin + Vincristine (CAV) Alternating with Ifosfamide + Etoposide (IE)
Cyclophosphamide + Vincristine + Doxorubicin + Dacarbazine (CYVADIC)
Doxorubicin + Dacarbazine (AD)
Mesna + Doxorubicin + Ifosfamide + Dacarbazine (MAID)
Single-Agent Regimens
Doxorubicin
Gemcitabine
Testicular Cancer
Adjuvant Therapy
Cisplatin + Etoposide + Bleomycin (PEB)
Advanced Disease
Cisplatin + Vinblastine + Bleomycin (PVB)
Etoposide + Bleomycin + Cisplatin (BEP)
Etoposide + Cisplatin (EP)
Etoposide + Ifosfamide + Cisplatin + Mesna (VIP) - Salvage Regimens
Vinblastine + Dactinomycin + Bleomycin (VAB-6)
Vinblastine + Ifosfamide + Cisplatin + Mesna (VeIP) - Salvage Regimens
Stage I Seminoma
Carboplatin
Thymoma
Cisplatin + Doxorubicin + Vincristine + Cyclophosphamide (ADOC)
Cisplatin + Etoposide
Cyclophosphamide + Doxorubicin + Cisplatin (CAP)
Thyroid Cancer
Combination Regimens
Doxorubicin + Cisplatin (AP)
Single-Agent Regimens
Doxorubicin
References
References
Front Matter
Preface
Search
GoogleAnalytics
All Resources
Current Resource
Go
i
https://webview.skyscape.com
GoogleAnalytics
Treatment Cycle A (cycles 1,3, 5, and 7)
i
GoogleAnalytics
Topic is locked.
Purchase entire reference Mobile/Web for $74.95
PURCHASE NOW
Already Purchased?
Sign In
;
